These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 15600254

  • 1. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
    Buraczynska K, Koziol-Montewka M, Majdan M, Tokarz A, Ksiazek A.
    Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis.
    Buraczynska K, Koziol-Montewka M, Majdan M, Ksiazek A.
    Mol Diagn; 2003 Nov; 7(3-4):175-80. PubMed ID: 15068388
    [Abstract] [Full Text] [Related]

  • 3. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
    Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Bárány P, Hoff CM, Holmes CJ, Suliman M, Lindholm B, Schalling M, Nordfors L.
    Kidney Int Suppl; 2003 May; (84):S172-6. PubMed ID: 12694338
    [Abstract] [Full Text] [Related]

  • 4. Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
    Katakami N, Kume S, Kaneto H, Uzu T, Kashiwagi A, Yamasaki Y, Maegawa H, Shimomura I.
    Endocr J; 2013 May; 60(4):457-71. PubMed ID: 23268804
    [Abstract] [Full Text] [Related]

  • 5. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
    Singh K, Prasad KN, Mishra P, Singh SK, Kharwar NK, Prasad N, Gupta A, Srivastava JK.
    Nephrology (Carlton); 2015 Jun; 20(6):387-91. PubMed ID: 25589331
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P, Bednarek-Skublewska A, Buraczyńska M.
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [Abstract] [Full Text] [Related]

  • 9. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A.
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [Abstract] [Full Text] [Related]

  • 10. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA, Mohammedi K, Bellili-Muñoz N, Driss F, Sanchez M, Fumeron F, Roussel R, Hadjadj S, Corrêa-Giannella ML, Marre M, Velho G.
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [Abstract] [Full Text] [Related]

  • 11. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy.
    Fawwaz S, Balbaa M, Fakhoury H, Borjac J, Fakhoury R.
    Saudi J Kidney Dis Transpl; 2017 Sep; 28(2):325-329. PubMed ID: 28352015
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
    Buraczyńska M, Ksiazek P, Łopatyński J, Spasiewicz D, Nowicka T, Ksiazek A.
    Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
    [Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P.
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [Abstract] [Full Text] [Related]

  • 15. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [Abstract] [Full Text] [Related]

  • 16. The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.
    Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I.
    Int Urol Nephrol; 2015 Mar; 47(3):551-6. PubMed ID: 25655256
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
    Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King AJ, Pereira BJ, HEMO Study Group.
    Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
    [Abstract] [Full Text] [Related]

  • 19. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease.
    Asakimori Y, Yorioka N, Yamamoto I, Okumoto S, Doi S, Hirai T, Taniguchi Y.
    Nephron; 2001 Oct; 89(2):219-23. PubMed ID: 11549906
    [Abstract] [Full Text] [Related]

  • 20. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, Chan JC.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.